Register your business to view and bid on tender opportunities.
Tender opportunities
Browse the list of tender opportunities and sign up for notifications to stay up to date. To download contracting information posted on CanadaBuys and contract history:
- check out our procurement and contracting datasets
- request your official supplier contract history letter
Content in some tender notices may not be available in both English and French. This is because the Official Languages Act does not apply to all public sector institutions. Learn more about our official languages requirements.
Notice categories:
10 of 10942
Title
|
Category
|
Open/amendment date
|
Closing date
|
Organization
|
---|---|---|---|---|
Development of Trivalent Vaccine | Services | 2012/07/26 | 2012/08/10 | Department of National Defence |
ANTHRAX VACCINE | Goods | 2022/05/30 | 2012/12/06 | Department of National Defence |
DEVELOPMENT OF AN EFFECTIVE MRNA-BASED AFRICAN SWINE FEVER VACCINE | Services | 2022/10/19 | 2022/11/09 | Canadian Food Inspection Agency |
Leveraging Vaccines Logistics | Services, Goods, Services related to goods | 2020/10/27 | 2020/10/29 | Public Works and Government Services… |
Vaccines Consumables | Goods | 2020/07/24 | 2020/07/29 | Public Health Agency of Canada |
PERTUSSIS VACCINES | Goods | 2020/11/23 | 2020/11/27 | Public Works and Government Services… |
Rotavirus vaccine | Goods | 2020/12/09 | 2020/12/18 | Public Works and Government Services… |
Anthrax Vaccine | Goods | 2016/10/17 | 2016/11/01 | Public Health Agency of Canada |
Meningococcal Vaccines | Goods | 2020/01/09 | 2020/01/29 | Public Works and Government Services… |
Adenovirus Vaccine | Goods | 2018/08/31 | 2018/09/17 | Department of National Defence |
Displaying 1 - 10 of
10 of 58661
58661
Title
|
Category
|
Award/amendment date
|
Closing date
|
Organization
|
---|---|---|---|---|
Vaccines (R&D) | Services | 2020/12/23 | N/A | Industry Canada |
Development of Trivalent Vaccine | Services | 2013/01/25 | N/A | Department of National Defence |
Meningococcal B Vaccine - | Goods | 2024/02/12 | 2025/03/31 | Department of Public Works and Government… |
Amend 008 - PERTUSSIS VACCINES - GlaxoSmithKline Inc. | Goods | 2024/06/28 | 2025/03/31 | Department of Public Works and Government… |
Meningococcal C and Quadrivalent Vaccines | Goods | 2024/02/01 | 2025/03/31 | Department of Public Works and Government… |
Rotavirus vaccine | Goods | 2021/02/10 | N/A | Public Works and Government Services… |
Meningococcal C Vaccine | Goods | 2016/01/28 | N/A | Public Works and Government Services… |
Varicella Vaccine | Goods | 2014/03/27 | N/A | Public Works and Government Services… |
Rotavirus Vaccine | Goods | 2015/01/27 | N/A | Public Works and Government Services… |
Rotavirus vaccine | Goods | 2021/02/10 | N/A | Public Works and Government Services… |
50 of 253557
Company name
|
Contract number
|
Organization
|
Award/amendment date
|
Contract / Amendment value
|
---|---|---|---|---|
CRUCELL VACCINES INC. | E60PH-10VACS/002/PH | Public Works and Government Services… | 2010/02/23 | CAD 29,316.00 |
CRUCELL VACCINES INC. | E60PH-07VACS/001/PH | Public Works and Government Services… | 2010/02/01 | CAD 200.00 |
CRUCELL VACCINES INC. | E60PH-07VACS/001/PH | Public Works and Government Services… | 2009/02/13 | CAD 14,400.00 |
GlaxoSmithKline Inc. | CW2248786 | Department of Public Works and Government… | 2024/02/12 | CAD 2,985,998.56 |
GlaxoSmithKline Inc. | CW2248786 | Department of Public Works and Government… | 2024/02/01 | CAD 101,590.00 |
GlaxoSmithKline Inc. | CW2248786 | Department of Public Works and Government… | 2023/05/01 | CAD 1,322,701.80 |
GlaxoSmithKline Inc. | CW2248786 | Department of Public Works and Government… | 2023/01/10 | CAD 72,258.48 |
GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/06/28 | CAD 219,924.00 |
GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/06/19 | CAD 219,924.00 |
GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/02/26 | CAD -195,300.00 |
GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2023/08/11 | CAD -3,641,262.00 |
Fuerste Vaccination Services Corp | F1585-190004/001/VIC | Fisheries and Oceans Canada | 2022/10/05 | CAD 401,500.00 |
Fuerste Vaccination Services Corp | F1585-190004/001/VIC | Fisheries and Oceans Canada | 2021/12/02 | CAD 357,500.00 |
Fuerste Vaccination Services Corp | F1585-190004/001/VIC | Fisheries and Oceans Canada | 2020/11/30 | CAD 102,900.00 |
Fuerste Vaccination Services Corp | F1585-190004/001/VIC | Fisheries and Oceans Canada | 2020/01/27 | CAD 264,600.00 |
GlaxoSmithKline Inc. | CW2270374 | Department of Public Works and Government… | 2024/02/01 | CAD 2,339,993.28 |
GlaxoSmithKline Inc. | CW2270374 | Department of Public Works and Government… | 2023/01/25 | CAD 5,957,012.52 |
Valneva Canada Inc. | E60PH-22RABV/002/PH | Department of Public Works and Government… | 2024/02/29 | CAD 2,730,000.00 |
Valneva Canada Inc. | E60PH-22RABV/002/PH | Department of Public Works and Government… | 2022/03/23 | CAD 257,720.00 |
Emergent BioSolutions Canada Inc. | 6D024-203933/001/PH | Public Health Agency of Canada (PHAC) | 2023/08/18 | CAD 10,280,424.00 |
GlaxoSmithKline Inc. | E60PH-22HEPB/001/PH | Department of Public Works and Government… | 2024/03/07 | CAD 8,257,621.63 |
Pfizer Canada ULC | CW2248827 | Department of Public Works and Government… | 2024/02/01 | CAD 15,404,505.36 |
Sanofi Pasteur Limited | CW2270377 | Department of Public Works and Government… | 2024/01/29 | CAD 7,613,072.88 |
Pfizer Canada ULC | CW2248827 | Department of Public Works and Government… | 2023/04/28 | CAD 1,358,510.40 |
Sanofi Pasteur Limited | CW2270377 | Department of Public Works and Government… | 2023/04/28 | CAD 1,032,595.20 |
Sanofi Pasteur Limited | CW2270377 | Department of Public Works and Government… | 2023/01/25 | CAD 12,853,741.74 |
Pfizer Canada ULC | CW2248827 | Department of Public Works and Government… | 2023/01/25 | CAD 27,610,434.00 |
Valneva Canada Inc. | E60PH-22JEVC/001/PH | Department of Public Works and Government… | 2024/02/15 | CAD 635,961.00 |
Valneva Canada Inc. | E60PH-22JEVC/001/PH | Department of Public Works and Government… | 2024/02/09 | CAD 635,961.00 |
Valneva Canada Inc. | E60PH-22JEVC/001/PH | Department of Public Works and Government… | 2024/02/02 | CAD 635,961.00 |
Valneva Canada Inc. | E60PH-22JEVC/001/PH | Department of Public Works and Government… | 2024/01/01 | CAD 635,961.00 |
Valneva Canada Inc. | E60PH-22JEVC/001/PH | Department of Public Works and Government… | 2023/11/15 | CAD 635,961.00 |
Valneva Canada Inc. | E60PH-22JEVC/001/PH | Department of Public Works and Government… | 2022/03/03 | CAD 3,540.00 |
Merck Canada Inc. | E60PH-22HEPB/002/PH | Department of Public Works and Government… | 2024/03/05 | CAD 8,078.40 |
Merck Canada Inc. | E60PH-22HEPB/002/PH | Department of Public Works and Government… | 2024/03/05 | CAD 4,248,519.84 |
Merck Canada Inc. | E60PH-22HEPB/002/PH | Department of Public Works and Government… | 2023/06/05 | CAD 8,078.40 |
Seqirus Canada Inc. | E60PH-22GFLU/002/PH | Department of Public Works and Government… | 2024/02/28 | CAD 2,771,982.00 |
Seqirus Canada Inc. | E60PH-22GFLU/002/PH | Department of Public Works and Government… | 2023/09/22 | CAD 14,037,898.70 |
Emergent Product Development Gaithersburg Inc | CW2343045 | Public Health Agency of Canada (PHAC) | 2024/03/01 | CAD 53,357,004.01 |
Emergent Product Development Gaithersburg Inc | CW2343045 | Public Health Agency of Canada (PHAC) | 2023/12/21 | CAD 53,357,004.01 |
GlaxoSmithKline Inc. | CW2355560 | Department of Public Works and Government… | 2024/03/25 | CAD 21,393,842.10 |
Merck Canada Inc. | CW2355553 | Department of Public Works and Government… | 2024/03/25 | CAD 42,655,585.92 |
Center for Vaccine Development - Mahidol University at Salaya | W7702-05R084/001/EDM | Department of National Defence | 2010/05/28 | CAD -122,029.00 |
EKOS Research Associates Inc | CW2238744 | Public Health Agency of Canada (PHAC) | 2023/09/23 | CAD 112,793.78 |
EKOS Research Associates Inc | CW2238744 | Public Health Agency of Canada (PHAC) | 2022/08/24 | CAD 112,793.78 |
Seqirus Canada Inc. | 6D034-162512/001/PH | Public Health Agency of Canada (PHAC) | 2024/04/11 | CAD -808,213.31 |
MARKETING LEGER INC/LEGER MARKETING INC | CW2267103 | Public Health Agency of Canada (PHAC) | 2023/08/31 | CAD 220,435.20 |
MARKETING LEGER INC/LEGER MARKETING INC | CW2267103 | Public Health Agency of Canada (PHAC) | 2023/01/04 | CAD 220,435.20 |
Advanis Inc | CW2355124 | Public Health Agency of Canada (PHAC) | 2024/03/21 | CAD 33,900.00 |
Sanofi Pasteur Limited | E60PH-21PERT/001/PH | Department of Public Works and Government… | 2024/02/14 | CAD -901,761.96 |
Useful links
Get an overview of our policies and guidelines, procurement process, and more.
Find out how to prepare for buying or selling to the Government of Canada.
Get all our latest news and learn about upcoming events.
Support
Contact us directly, or find your answers using resource guides.